DK3194618T3 - Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma - Google Patents
Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma Download PDFInfo
- Publication number
- DK3194618T3 DK3194618T3 DK15771837.0T DK15771837T DK3194618T3 DK 3194618 T3 DK3194618 T3 DK 3194618T3 DK 15771837 T DK15771837 T DK 15771837T DK 3194618 T3 DK3194618 T3 DK 3194618T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosticization
- neoplasma
- kits
- compositions
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000000955 neuroendocrine Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462050465P | 2014-09-15 | 2014-09-15 | |
| PCT/US2015/050274 WO2016044330A1 (en) | 2014-09-15 | 2015-09-15 | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3194618T3 true DK3194618T3 (da) | 2021-07-12 |
Family
ID=54207775
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15771837.0T DK3194618T3 (da) | 2014-09-15 | 2015-09-15 | Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma |
| DK21169154.8T DK3929303T3 (da) | 2014-09-15 | 2015-09-15 | Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21169154.8T DK3929303T3 (da) | 2014-09-15 | 2015-09-15 | Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastro-entero-pankreatisk neuroendokrint neoplasma |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10407730B2 (enExample) |
| EP (2) | EP3194618B1 (enExample) |
| JP (2) | JP6782700B2 (enExample) |
| KR (2) | KR20250021631A (enExample) |
| CN (1) | CN107208132A (enExample) |
| AU (3) | AU2015317893B2 (enExample) |
| CA (1) | CA2959670C (enExample) |
| DK (2) | DK3194618T3 (enExample) |
| ES (2) | ES3013599T3 (enExample) |
| IL (2) | IL250867B (enExample) |
| MX (2) | MX386919B (enExample) |
| PL (2) | PL3929303T3 (enExample) |
| WO (1) | WO2016044330A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015317893B2 (en) | 2014-09-15 | 2021-05-20 | Clifton Life Sciences LLC | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
| BR112019024481A2 (pt) * | 2017-05-25 | 2020-07-14 | Liquid Biopsy Research LLC | métodos para detecção de melanoma |
| IL317236A (en) * | 2017-11-30 | 2025-01-01 | Liquid Biopsy Res Llc | Predicting peptide receptor radiotherapy using gene expression testing |
| CN108048564B (zh) * | 2018-02-09 | 2021-03-05 | 中国科学院昆明动物研究所 | 人glt8d1基因的新用途 |
| SG11202100047YA (en) * | 2018-07-30 | 2021-02-25 | Agency Science Tech & Res | Method and system for assessing fibrosis in a tissue sample |
| US20210108259A1 (en) | 2019-10-10 | 2021-04-15 | Liquid Biopsy Research LLC | Compositions, methods and kits for biological sample and rna stabilization |
| FR3110764B1 (fr) | 2020-05-20 | 2024-05-10 | Quantum Surgical | Méthode de prédiction de la récidive d’une lésion par analyse d’images |
| CN113215255B (zh) * | 2021-04-26 | 2022-04-05 | 山东天川精准医疗科技有限公司 | 用于肝癌早期诊断或预后的生物标记物及其用途 |
| WO2024015968A2 (en) * | 2022-07-15 | 2024-01-18 | Emendobio Inc. | Strategies for knock-ins at aplp2 safe harbor sites |
| JP2025532965A (ja) * | 2022-09-30 | 2025-10-03 | リキッド バイオプシー リサーチ リミティド ライアビリティ カンパニー | 唾液での神経内分泌がん検出方法 |
| CN117292755A (zh) * | 2023-08-09 | 2023-12-26 | 郑州大学 | 多模态临界边生物标志物识别方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050084883A1 (en) * | 2003-08-25 | 2005-04-21 | The Johns Hopkins University School Of Medicine | Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis |
| EP3590956A1 (en) | 2008-06-12 | 2020-01-08 | Ipsen Bioinnovation Limited | Suppression of neuroendocrine diseases |
| ES2656487T3 (es) * | 2011-03-01 | 2018-02-27 | Yale University | Evaluación de la respuesta a la terapia de neoplasmas neuroendocrinos gastroenteropancreáticas (GEP-NEN) |
| AU2015317893B2 (en) | 2014-09-15 | 2021-05-20 | Clifton Life Sciences LLC | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
-
2015
- 2015-09-15 AU AU2015317893A patent/AU2015317893B2/en active Active
- 2015-09-15 KR KR1020257003150A patent/KR20250021631A/ko active Pending
- 2015-09-15 CA CA2959670A patent/CA2959670C/en active Active
- 2015-09-15 DK DK15771837.0T patent/DK3194618T3/da active
- 2015-09-15 US US14/855,229 patent/US10407730B2/en active Active
- 2015-09-15 MX MX2017003370A patent/MX386919B/es unknown
- 2015-09-15 KR KR1020177010086A patent/KR102762958B1/ko active Active
- 2015-09-15 DK DK21169154.8T patent/DK3929303T3/da active
- 2015-09-15 JP JP2017533744A patent/JP6782700B2/ja active Active
- 2015-09-15 PL PL21169154.8T patent/PL3929303T3/pl unknown
- 2015-09-15 ES ES21169154T patent/ES3013599T3/es active Active
- 2015-09-15 WO PCT/US2015/050274 patent/WO2016044330A1/en not_active Ceased
- 2015-09-15 ES ES15771837T patent/ES2881474T3/es active Active
- 2015-09-15 EP EP15771837.0A patent/EP3194618B1/en active Active
- 2015-09-15 CN CN201580061761.0A patent/CN107208132A/zh active Pending
- 2015-09-15 EP EP21169154.8A patent/EP3929303B1/en active Active
- 2015-09-15 PL PL15771837T patent/PL3194618T3/pl unknown
-
2017
- 2017-03-01 IL IL250867A patent/IL250867B/en active IP Right Grant
- 2017-03-14 MX MX2021012347A patent/MX2021012347A/es unknown
-
2019
- 2019-08-01 US US16/528,864 patent/US11168372B2/en active Active
-
2020
- 2020-10-20 JP JP2020175701A patent/JP7157788B2/ja active Active
-
2021
- 2021-03-09 IL IL281355A patent/IL281355B/en unknown
- 2021-08-06 AU AU2021212151A patent/AU2021212151B2/en active Active
- 2021-11-08 US US17/521,205 patent/US12258633B2/en active Active
-
2023
- 2023-11-03 AU AU2023258444A patent/AU2023258444A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3194618T3 (da) | Sammensætninger, fremgangsmåder og kits til diagnosticering af et gastroenteropankreatisk neuroendokrin neoplasma | |
| DK3277717T3 (da) | En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf | |
| DK3782639T3 (da) | Sammensætninger og fremgangsmåder til internalisering af enzymer | |
| DK3152312T3 (da) | Fremgangsmåder og sammensætninger til modifikation af et mållocus | |
| DK3137605T3 (da) | Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression | |
| DK3180492T3 (da) | Borehulsværktøjer og fremgangsmåder til brug af sådanne | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3689609T3 (da) | Transplantatstillads til bruskreparation og en fremgangsmåde til fremstilling af samme | |
| DK3245225T3 (da) | Sammensætninger og fremgangsmåder til behandling og detektering af cancere | |
| DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3940352T3 (da) | Fremgangsmåde til diagnosticering af vægte | |
| DK3359281T3 (da) | Fremgangsmåde til udtrækning af CO2 | |
| DK2924093T3 (da) | Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse | |
| DK3384274T3 (da) | Fremgangsmåder til prøvekarakterisering | |
| DK3134084T3 (da) | Fremgangsmåde til behandling af lungeadenokarcinom | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3212802T3 (da) | Fremgangsmåde til detektering af kontamination med hussvamp | |
| DK3113675T3 (da) | Fremgangsmåde til overførsel af point-of-care-testdata | |
| DK3520591T3 (da) | Fremgangsmåde til spredning af gødningsmidler | |
| FI20146115A7 (fi) | Menetelmä kemikaalitestausta varten | |
| DK3186640T3 (da) | Fremgangsmåde til påvisning af anomalier i hæmoglobin | |
| DK3212659T3 (da) | Midler og fremgangsmåder til stedspecifik funktionalisering af polypeptider | |
| DK3274158T3 (da) | Fremgangsmåde til isolering af komplekse undersøiske strukturer | |
| DK3222730T3 (da) | Plasmider og fremgangsmåde til opnåelse af virale partikler |